Biodexa Pharmaceuticals Announces 1 ADR For 400 Ordinary Share Ratio Change Effective July 5, 2023
22 June 2023Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")ADR Ratio ChangeBiodexa Pharmaceuticals PLC (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary